Risk decilea | Tranexamic acid (TXA) | Placebo | Risk ratio (95 % CI) | ||
---|---|---|---|---|---|
Death due to bleeding | Received TXA | Death due to bleeding | Received placebo | ||
1 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
2 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
3 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
4 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
5 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
6 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
7 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
8 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
9 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
10 | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
Overall | NN (X %) | N NNN | NN (X %) | N NNN | X.XX (X.XX–X.XX) |
(I 2 = X %, p = 0.XX) |